| abstract |
The invention is based on the finding that compounds of formula (I) have unexpectedly proven to be very potent and selective inhibitors of the adenosine A1 receptor. Adenosine A1 antagonists may be useful for the prevention and / or treatment of many diseases, including cardiac and circulatory disorders, degenerative disorders of the central nervous system, respiratory disorders, and many conditions for which diuretic treatment is appropriate. In one embodiment, the invention describes a compound of formula (I) |